The Pre-treatment Lymphocyte-to-Monocyte Ratio Predicts Efficacy in Metastatic Colorectal Cancer Treated With TAS-102 and Bevacizumab

Kuramochi, H; Yamada, T; Yoshida, Y; Matsuda, A; Kamiyama, H; Kosugi, C; Ishibashi, K; Fukazawa, A; Ihara, K; Sonoda, H; Yoshimatsu, K; Yoshida, H; Hasegawa, S; Sakamoto, K; Ishida, H; Koda, K

Yamada, T (corresponding author), Nippon Med Sch, Dept Gastrointestinal & Hepatobiliary Pancreat Su, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138603, Japan.

ANTICANCER RESEARCH, 2021; 41 (6): 3131

Abstract

Background/Aim: Our multicenter phase II TAS-CC3 study demonstrated favorable median progression-free survival (PFS) and overall survival (OS) of 32 m......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索